Ursodeoxycholic acid and methotrexate for primary sclerosing cholangitis: A pilot study

American Journal of Gastroenterology

Volumn 91, Issue 3, 1996, Pages 511-515

  Lindor, Keith D ^a   Jorgensen, Roberta A ^b   Anderson, Monte L ^b   Gores, Gregory J ^b   Hofmann, Alan F ^b   LaRusso, Nicholas F ^b  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; URSODEOXYCHOLIC ACID;

ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; CHOLESTASIS; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HAIR LOSS; HUMAN; LIVER FIBROSIS; LIVER INJURY; LUNG TOXICITY; MALE; ORAL DRUG ADMINISTRATION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL;

ADULT; CHI-SQUARE DISTRIBUTION; CHOLANGITIS, SCLEROSING; CHRONIC DISEASE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METHOTREXATE; MIDDLE AGED; PILOT PROJECTS; STATISTICS, NONPARAMETRIC; URSODEOXYCHOLIC ACID;

EID: 0029935080     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Chapman RWG, Arborgh BAM, Rhodes JM, et al. Primary sclerosing cholangitis: A review of its clinical features, cholangiography, and hepatic histology. Gut 1980;21:870-7.
2. Wiesner RH, LaRusso NF. Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology 1980;79:200-6.
3. Crippin JS, Lindor KD. Primary sclerosing cholangitis: Etiology and immunology. Eur J Gastroenterol Hepatol 1992;4:261-5.
4. Lindor KD, Wiesner RH, MacCarty RL, et al. Advances in primary sclerosing cholangitis. Am J Med 1990;89:73-80.
5. Lindor KD, Wiesner RH, Colwell LJ, et al. The combination of prednisone and colchicine in patients with primary sclerosing cholangitis. Am J Gastroenterol 1991;86:57-61.
6. Allison MC, Burroughs AK, Noone P, et al. Biliary lavage with corticosteroids in primary sclerosing cholangitis. A clinical, cholangiographic, and bacteriological study. J Hepatol 1986;3:118-22.
7. Knox TA, Kaplan MM. A double-blind controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitis. Gastroenterology 1994;106:494-9.
8. O'Brien CB, Senior JR, Arora-Mirchandani R, et al. Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: A 30-month pilot study. Hepatology 1991;14:838-47.
9. Beuers U, Spengler U, Kruis W, et al. Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial. Hepatology 1992;16:707-14.
10. Stiehl A, Walker S, Stiehl L, et al. Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period. J Hepatol 1994;20: 57-64.
11. Zachariae H. Methotrexate side-effects. Br J Dermatol 1990;122-33S.
12. Shergy WJ, Polisson RP, Caldwell DS, et al. Methotrexate-associated hepatotoxicity: Retrospective analysis of 210 patients with rheumatoid arthritis. Am J Med 1988;85:771-4.
13. Kremer JM, Lee RG, Tolman KG. Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy. A prospective study with baseline and sequential biopsy samples. Arthritis Rheum 1989;32:121-7.
14. Ludwig J, Dickson ER, McDonald GSA. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch Pathol Anat 1978;379:103-12.
15. Dickson ER, Murtaugh PA, Wiesner RH. Primary sclerosing cholangitis: Refinement and validation of survival models. Gastroenterology 1992;103:1893-901.
16. Rossi SS, Converse JL, Hofmann AF. High pressure liquid chromatographic analysis of conjugated bile acids in human bile: Simultaneous resolution of sulfated and unsulfated lithocholyl amidates and the common conjugated bile acids. J Lipid Res 1987;28:589-95.
17. Fisher RL, Hofmann AF, Converse JL, et al. Lack of relationship between hepatotoxicity and lithocholic acid sulfation during chenodiol therapy in the national cooperative gallstone study. Hepatology 1991; 14:454-63.
18. Lindor KD, Dickson ER, Baldus WP, et al. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology 1994;106: 1284-90.
19. Sharma A, Provenzale D, McKusick A, et al. Interstitial pneumonitis after low-dose methotrexate therapy in primary biliary cirrhosis. Gastroenterology 1994;107:266-70.
20. White DA, Rankin JA, Stover DE, et al. Methotrexate pneumonitis. Am Rev Respir Dis 1989;139:18-21.
21. Green L, Schattner A, Berkenstadt H. Severe reversible interstitial pneumonitis induced by low dose methotrexate: Report of a case and review of the literature. J Rheumatol 1988;15:110-2.